Efficacy of granulocyte colony stimulating factor and N-acetyl cysteine therapies in patients with severe alcoholic hepatitis
Clinical Gastroenterology and Hepatology Feb 20, 2018
Singh V, et al. - Researchers compared the efficacy of standard medical therapy with pentoxifylline to treatment with a combination of granulocyte colony stimulating factor (GCSF) and standard medical therapy as well as to the combination of N-acetyl cysteine (NAC), GCSF, and standard medical therapy in patients with severe alcoholic hepatitis (AH). Compared to standard therapy, administration of GCSF was found to improve liver function and increase survival times in patients with severe AH. No evidence was found regarding the benefit of adding NAC to GCSF.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries